| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |